As of 2025-09-16, the Relative Valuation of Altimmune Inc (ALT) is (13.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.63 USD, the upside of Altimmune Inc based on Relative Valuation is -473.8%.
The range of the Relative Valuation is (10.90) - (15.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 15.4x | 13.7x |
| Forward P/E multiples | 10.9x - 16.8x | 13.6x |
| Fair Price | (10.90) - (15.31) | (13.57) |
| Upside | -400.2% - -521.8% | -473.8% |
| Date | P/E |
| 2025-09-15 | -3.61 |
| 2025-09-12 | -3.66 |
| 2025-09-11 | -3.71 |
| 2025-09-10 | -3.69 |
| 2025-09-09 | -3.80 |
| 2025-09-08 | -3.73 |
| 2025-09-05 | -3.80 |
| 2025-09-04 | -3.58 |
| 2025-09-03 | -3.70 |
| 2025-09-02 | -3.77 |
| 2025-08-29 | -3.85 |
| 2025-08-28 | -3.73 |
| 2025-08-27 | -3.69 |
| 2025-08-26 | -3.46 |
| 2025-08-25 | -3.41 |
| 2025-08-22 | -3.56 |
| 2025-08-21 | -3.55 |
| 2025-08-20 | -3.65 |
| 2025-08-19 | -3.64 |
| 2025-08-18 | -3.58 |
| 2025-08-15 | -3.65 |
| 2025-08-14 | -3.70 |
| 2025-08-13 | -3.76 |
| 2025-08-12 | -3.64 |
| 2025-08-11 | -3.40 |
| 2025-08-08 | -3.47 |
| 2025-08-07 | -3.54 |
| 2025-08-06 | -3.62 |
| 2025-08-05 | -3.69 |
| 2025-08-04 | -3.60 |
| 2025-08-01 | -3.63 |
| 2025-07-31 | -3.71 |
| 2025-07-30 | -3.67 |
| 2025-07-29 | -3.85 |
| 2025-07-28 | -4.05 |
| 2025-07-25 | -4.10 |
| 2025-07-24 | -4.13 |
| 2025-07-23 | -4.32 |
| 2025-07-22 | -4.22 |
| 2025-07-21 | -4.07 |
| 2025-07-18 | -4.10 |
| 2025-07-17 | -4.07 |
| 2025-07-16 | -4.20 |
| 2025-07-15 | -4.20 |
| 2025-07-14 | -4.28 |
| 2025-07-11 | -4.16 |
| 2025-07-10 | -4.43 |
| 2025-07-09 | -4.77 |
| 2025-07-08 | -4.61 |
| 2025-07-07 | -4.46 |